The most straightforward explanation of the apparent famotidine activity as a COVID-19 therapy is that the drug acts via its antagonism or inverse-agonism of histamine signaling and via its arrestin biased activation—all a result of famotidine binding to histamine receptor H2. Here, SAG is linked to COVID-19.